May, 2017

List of private providers for lung cancer patients

We continue to receive enquiries from lung cancer patients with the PD-L1 expression about access to KEYTRUDA (Pembrolizumab). Because KEYTRUDA is not funded in New Zealand for all registered indications, patients may need to see a private provider to have this immunotherapy treatment prescribed. Some doctors working in public hospitals may be able to help […]

Suicide Risk Quadruples After Lung Cancer Diagnosis

By Foreign Affairs Publisher / May 25, 2017 / Comments Off on Suicide Risk Quadruples After Lung Cancer Diagnosis People with lung cancer have a strikingly higher-than-normal risk of suicide, a new study finds. While a cancer diagnosis on its own significantly raises the risk of suicide, the study found that a lung cancer diagnosis […]